Pions, protectors. Examples of a vigorous decade in radiotherapy.
D004999:Amifostine / Q000008:administration & dosage* / Q000009:adverse effects; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004601:Elementary Particles; D004735:Energy Transfer; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D051379:Mice; D009502:Neutrons / Q000627:therapeutic use; D009946:Organothiophosphorus Compounds / Q000008:administration & dosage*; D010315:Particle Accelerators; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D011837:Radiation-Protective Agents / Q000008:administration & dosage*; D011879:Radiotherapy Dosage; D012062:Relative Biological Effectiveness; D012867:Skin / Q000473:pathology / Q000528:radiation effects
D000970:Antineoplastic Agents; D009946:Organothiophosphorus Compounds; D011837:Radiation-Protective Agents; D004999:Amifostine